Bone grafts as vancomycin carriers in local therapy of resistant infections.

Folia Microbiologica
P MelicherčíkA Sosna

Abstract

The level of an antibiotic capable of inhibiting the etiological agent at the site of infection is an essential prerequisite for successful antibiotic therapy. In some cases, locally applied antibiotics may compensate for limitations of systemic administration and shorten systemic therapy. We aimed at verifying to what extent vancomycin (Van) bound to ground bone grafts is usable in the treatment of serious infections. The levels of released Van significantly exceeded the Van minimum inhibitory concentration, which can suppress Van-sensitive staphylococci and Van intermediate Staphylococcus aureus, for the whole period of a 16-day measurement. Our results indicate that bone grafts can be used as Van carriers in therapy of osteomyelitis caused by Van-sensitive Staphylococcus strains.

References

Sep 12, 2000·The Journal of Antimicrobial Chemotherapy·H WinklerA Georgopoulos
Dec 19, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S K Fridkin
Nov 1, 2002·The Lancet Infectious Diseases·Christof von EiffChristine Heilmann
Apr 4, 2003·The New England Journal of Medicine·Soju ChangUNKNOWN Vancomycin-Resistant Staphylococcus aureus Investigative Team
Sep 24, 2004·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·O MelterH de Lencastre
Oct 1, 2005·Acta Orthopaedica·Eivind WitsøKåre Bergh
Sep 25, 2007·International Journal of Antimicrobial Agents·Peter C Appelbaum
Mar 26, 2008·Critical Care Clinics·Burke A Cunha
Dec 2, 2008·The Journal of Bone and Joint Surgery. British Volume·H WinklerF Menschik
May 2, 2009·Clinical Orthopaedics and Related Research·Javad ParviziRichard H Rothman
Oct 2, 2009·Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA·Pietro RandelliLuca Vaienti
Jun 23, 2010·Seminars in Plastic Surgery·Henry S Fraimow
Sep 3, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Helen BoucherRaymund R Razonable

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.